1. Home
  2. PETS vs CKPT Comparison

PETS vs CKPT Comparison

Compare PETS & CKPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PETS
  • CKPT
  • Stock Information
  • Founded
  • PETS 1996
  • CKPT 2014
  • Country
  • PETS United States
  • CKPT United States
  • Employees
  • PETS N/A
  • CKPT N/A
  • Industry
  • PETS Retail-Drug Stores and Proprietary Stores
  • CKPT Biotechnology: Pharmaceutical Preparations
  • Sector
  • PETS Consumer Staples
  • CKPT Health Care
  • Exchange
  • PETS Nasdaq
  • CKPT Nasdaq
  • Market Cap
  • PETS 87.1M
  • CKPT 80.3M
  • IPO Year
  • PETS N/A
  • CKPT 2017
  • Fundamental
  • Price
  • PETS $3.79
  • CKPT $2.58
  • Analyst Decision
  • PETS Buy
  • CKPT Strong Buy
  • Analyst Count
  • PETS 2
  • CKPT 5
  • Target Price
  • PETS $5.25
  • CKPT $22.60
  • AVG Volume (30 Days)
  • PETS 495.7K
  • CKPT 421.7K
  • Earning Date
  • PETS 07-29-2024
  • CKPT 08-12-2024
  • Dividend Yield
  • PETS 7.92%
  • CKPT N/A
  • EPS Growth
  • PETS N/A
  • CKPT N/A
  • EPS
  • PETS N/A
  • CKPT N/A
  • Revenue
  • PETS $281,064,000.00
  • CKPT $68,000.00
  • Revenue This Year
  • PETS $2.07
  • CKPT N/A
  • Revenue Next Year
  • PETS $4.31
  • CKPT $102,695.70
  • P/E Ratio
  • PETS N/A
  • CKPT N/A
  • Revenue Growth
  • PETS 9.54
  • CKPT N/A
  • 52 Week Low
  • PETS $3.63
  • CKPT $1.30
  • 52 Week High
  • PETS $15.08
  • CKPT $3.62
  • Technical
  • Relative Strength Index (RSI)
  • PETS 42.93
  • CKPT 69.30
  • Support Level
  • PETS $3.63
  • CKPT $2.05
  • Resistance Level
  • PETS $4.13
  • CKPT $2.78
  • Average True Range (ATR)
  • PETS 0.17
  • CKPT 0.18
  • MACD
  • PETS -0.00
  • CKPT 0.04
  • Stochastic Oscillator
  • PETS 29.63
  • CKPT 74.36

About PETS PetMed Express Inc.

PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies primarily to retail consumers.

About CKPT Checkpoint Therapeutics Inc.

Checkpoint Therapeutics Inc is an immuno-oncology biopharmaceutical company based in the USA. It focuses on the acquisition, development, and commercialization of novel, non-chemotherapy, immune-enhanced combination treatments for patients with solid tumor cancers. Its licensed portfolio of antibodies includes targeting programmed cell death-ligand 1 (PD-L1), glucocorticoid-induced TNFR-related protein (GITR) and carbonic anhydrase IX (CAIX). The company is evaluating its lead small-molecule, targeted anti-cancer agent, olafertinib, a third-generation epidermal growth factor receptor ("EGFR") inhibitor, as a potential new treatment for patients with EGFR mutation-positive non-small cell lung cancer.

Share on Social Networks: